CSBR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CSBR shares is 28, representing 49.09% of the company's common stock.

RENAISSANCE TECHNOLOGIES LLC, in the last quarter, reduced its stake in CSBR by -0.08% restricting it's holding to 124.69 thousand shares of worth nearly $611.00K. NORTHERN TRUST CORP also lessened -4.96% of the CSBR shares from its portfolio, reducing its holding to 42.69 thousand shares of worth $209.18K. BANK OF NEW YORK MELLON CORP also shunned CSBR shares holding by -13.08% last quarter which brought its holding to 26.75 thousand shares worth $131.07K.

As per its latest 13F filing, STIFEL FINANCIAL CORP increased its stake in CSBR by 100% in the last quarter. The institutional holder raised its holding to 11.19 thousand shares having worth more than $54.84K. TOCQUEVILLE ASSET MANAGEMENT L.P. also added 0.01% more shares of CSBR to its portfolio, raising its holding to 684.63 thousand shares of worth $3.35M. VANGUARD GROUP INC also increased its CSBR shares holding by 3.34% which brought its holding to 85.6 thousand shares worth $419.46K.

The insider with the most stakes in CSBR is Battery Ventures IX, L.P. , 10 percent owner at the company. Additionally, CSBR stock is highly held by 10 percent owner BROWN MICHAEL MAURICE and Chairman, President and CEO CHAMPIONS SPORTS INC among others.

Company executives, directors, and other insiders own 26.33% percent of Champions Oncology, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CSBR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BREITFELD PHILIP P., MORRIS RONNIE, and NEW ENTERPRISE ASSOCIATES 14, L.P..

There have been 0 transaction(s) during the past 6-months in which Champions Oncology, Inc. insiders have bought stock, totalling 0 shares

Around 0 Champions Oncology, Inc. shares are held by insiders, which represents about 26.33% of CSBR stock.

CSBR 10 percent owner, Battery Ventures IX, L.P. holds the largest portfolio of the company's shares. CSBR shares owned by Battery total nearly 22.28 million.

STIFEL FINANCIAL CORP is the largest institutional owner in CSBR which holds 11.19 thousand shares worth $54.84K or 0.08% of the total CSBR shares outstanding followed by BATTERY MANAGEMENT CORP. with ownership of 2.42 million shares representing 17.81% of the CSBR ownership. TOCQUEVILLE ASSET MANAGEMENT L.P. is the third largest stakeholder with 684.63 thousand shares or 5.04% of the ownership worth more than $3.35M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CSBR is concerned, it is a stock which is optionable.

Number of CSBR shares short is 217.88K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 13.70M shares of CSBR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CSBR has 4.79M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CSBR is 20.86.